CRP and cardiovascular disorder: Therefore, the recommendations from The United States Preventive Services Task Force3 and the 2016 European Guidelines on cardiovascular disease prevention4 do not support CRP monitoring of asymptomatic adults due to the slight added benefit of modifying risk reclassification by adding CRP to the existing CVD risk assessment models, though the CRP assessment may be used as part of refined risk assessment in patients with moderate CVD risk profile4.